The WT1 tumor suppressor gene, implicated in hereditofamilial and sporadic Wilms' tumor, is required for normal renal development and is up-regulated during the mesenchymal-epithelial transition. NIH3T3 ®bro-blasts overexpressing WT1 were less proliferative, larger in size and more ®rmly attached to tissue culture plastic, suggesting an alteration of their state of dierentiation. These cells were studied in vivo by subcutaneous injection into nude mice. The resulting tumors exhibited epithelioid histopathology and formed desmosome-like structures. Molecular analyses of these WT1 expressing ®broblasts grown in culture and in nude mice revealed signi®cant alterations in the expression of many kidney epithelial markers. These studies indicate that WT1 expression can initiate features of a program of epithelial dierentiation consistent with a prominent role for WT1 in the mesenchymal epithelial transition that occurs during renal development. Through this work we identi®ed a number of novel target genes for the WT1 transcription factor, including uvomorulin, integrin a8 and perlecan, and suggest that WT1 may activate the IGF-II gene, also implicated in the development of Wilms' tumor.
Introduction
Wilms' tumor is a childhood tumor of the kidney with a triphasic morphology, in which undierentiated blastemal elements are present along with stromal and epithelial elements (Beckwith et al., 1990) , recapitulating dierent phases of normal kidney development. This suggests that Wilms' tumor results from an abnormal dierentiation program in the kidney. The Wilms' tumor suppressor gene WT1 was cloned by virtue of its position on 11p13, a chromosomal region that is constitutionally deleted in the WAGR (Wilms' tumor-aniridia-genital anomaliesmental retardation) syndrome (Call et al., 1990; Gessler et al., 1990) , (reviewed in Coppes et al., 1993; Hastie, 1994; Reddy and Licht, 1996) . The WT1 gene is homozygously mutated and/or deleted in 10% of Wilms' tumors, while overexpression of wild-type WT1 is found in the other 90% of Wilms' tumors (Gerald et al., 1992) . The infrequency of WT1 mutation in Wilms' tumor may be explained by the involvement of other Wilms' tumor-associated loci located at chromosome 11p15 or 16q (Henry et al., 1989; Hu et al., 1992; Hu and Saunders, 1993; Maw et al., 1992) or as yet undiscovered genetic pathways.
Several lines of evidence point to a role of WT1 in epithelial dierentiation. Firstly, the level of WT1 expression is directly correlated with the degree of epithelial dierentiation of Wilms' tumor (Miwa et al., 1992) . Secondly, constitutional mutations of WT1 present in the WAGR and Denys ± Drash syndromes are associated with renal and genitourinary abnormalities. Thirdly, WT1 is expressed in a distinct temporalspatial pattern during renal development consistent with a regulatory role in this process. During early nephrogenesis, the ureteric bud-induced mesenchymalepithelial transition (MET) starts with the condensation of loose mesenchymal cells that give rise to a multicellular aggregates called primary vesicles (SaxeÂ n, 1987) . The primary vesicles then dierentiate further into a form of epithelium known as the comma and Sshaped bodies which subsequently give rise to mature glomeruli. The level of WT1 expression is low in uncondensed mesenchymal cells and begins to rise with the onset of mesenchymal condensation, and peaks during development of the comma and S-shaped bodies (Pritchard-Jones et al., 1990) .
WT1 expression starts to decrease with the formation of the early glomerulus, and in the mature glomerulus, WT1 expression is only observed in the podocyte layer, potentially having a tonic role in the dierentiated state of these cells. Lastly, mice homozygous for targeted disruption of the WT1 locus (WT1
7/7
) fail to exhibit blastemal mesenchymal cell condensation during early kidney development and never form comma or S-shaped bodies (Kreidberg et al., 1993) . This is a cell-autonomous defect as wild-type ureteric bud also fails to induce condensation of WT1 7/7 mesenchyme. WT1 suppresses tumorigenicity of a Wilms' tumor cell line (Haber et al., 1993) as well as other cells such as osteosarcoma cells, CV1 cells and ®broblasts (Englert et al., 1995; Luo et al., 1995; Menke et al., 1996; Werner et al., 1995) . We previously showed that the (A) isoform of WT1 (-17aa and -KTS) inhibits growth and tumorigenicity of ras-transformed fibroblasts (Luo et al., 1995) , and could slow the growth and alter the morphology of non-transformed NIH3T3 cells. Both transformed and non-transformed NIH3T3 cells expressing WT1 were characterized by a¯at morphology and a decreased rate of proliferation (Luo et al., 1995) . This suggested that WT1 expression in ®broblast could mimic some of the eects of WT1 during the induction of dierentiation (MET) in early kidney development. The MET is characterized by changes in the expression pattern of various markers of kidney dierentiation which include extracellular matrix proteins (ECM), cellular adhesion molecules (CAM) and intracellular structural proteins important for morphological and structural transition from mesenchyme to epithelium (Ekblom, 1989) .
The WT1 gene encodes a transcription factor that belongs to the Cys2-His2 zinc-®nger family (Call et al., 1990; Gessler et al., 1990; Reddy and Licht, 1996) . WT1 can transcriptionally regulate a number of growth and dierentiation related genes in co-transfection assays including insulin-like growth factor II (IGF-II) (Drummond et al., 1992; Nichols et al., 1995) , insulinlike growth factor I receptor (IGF-IR) (Werner et al., 1993) , platelet-derived growth factor a-chain (PDGF-a) (Gashler et al., 1993; Wang et al., 1992) , transforming growth factor b (TGF-b) (Dey et al., 1994) , retinoic acid receptor-a (RAR-a) (Goodyer et al., 1995) , Pax-2 (Ryan et al., 1995) , syndecan-1 (Cook et al., 1996) and others (reviewed in (Reddy and Licht, 1996) ). Epidermal growth factor receptor (EGF-R) downregulation by WT1 may contribute to tumor suppression by inducing apoptosis (Englert et al., 1995) and syndecan induction may be important for renal dierentiation (Cook et al., 1996) . However the signi®cance of the other putative target genes for tumor suppression and induction of renal differentiation remains to be elucidated.
In this report, we examined the ability of the WT1 (-17aa and -KTS) protein to induce features of epithelial dierentiation in a mesenchymal cell line. Examination of the histopathology of tumors developing from WT1-expressing NIH3T3 cells by light and electron microscopy revealed morphological features of epithelioid dierentiation. Molecular analyses at the RNA and protein levels showed that expression of WT1 was associated with altered expression of markers of renal epithelial dierentiation. These data support a direct role for WT1 in the development of the dierentiated renal epithelial phenotype and suggest a new set of target genes that may be regulated by WT1 in vivo.
Results

WT1-expressing mesenchymal cells form tumors with epithelial features
During the course of studies with the WT1 (A) isoform (Luo et al., 1995) , we created several lines of NIH3T3 cells stably expressing the WT1 gene under the control of the Rous sarcoma virus (RSV) LTR. By both Northern blotting and Western blotting signi®cant levels of WT1 were expressed in these cells (Figure 1 and Luo et al., 1995) . Engineered expression of WT1 caused growth inhibition and altered cellular morphology. WT1-expressing non-transformed NIH3T3 cell lines WR14, WR16, WR35, as well as the ras transformed cell line VW9, cells were signi®cantly larger,¯atter and more ®rmly attached to the tissue culture dish, while the ras transformed (e.g. VAC1) or wild-type NIH3T3 cells were small, refractile and fusiform in shape (Luo et al., 1995) . We reasoned that some of the eects of WT1 on cellular morphology might be accentuated by growing the cells in the presence of extracellular matrix in vivo. Therefore, WT1-expressing NIH3T3 cells, WT1-expressing ras-transformed NIH3T3 cells and wild-type NIH3T3 negative control were injected into nude mice. These`non-transformed' NIH3T3 cells spontaneously formed tumors with prolonged latency in nude mice if enough cells (approximately 1 ± 2610 7 cells) were injected (Rubin, 1993) . WR16 and wild-type NIH3T3 cells formed tumors at very similar rates. Tumors of an average cross-sectional surface area of 0.36 cm 2 formed about 50 days post-injection in both WR16 and wildtype NIH3T3 control. WR35 formed tumor much earlier at about 30 days post-injection. We believe that the rate of tumor formation in non-transformed NIH3T3 cells has little to do with the rate of growth of these cell line in vitro, but may be a function of the timing of spontaneous mutations which leads to transformation after injection (Rubin, 1993; Santos et al., 1983; Wahrman et al., 1985) . WT1 expression in the tumors derived from WT1-expressing NIH3T3 cells remained detectable either by Northern blot or RT ± PCR analysis (Figure 2b, c) Morphological alterations seen previously in vitro correlated well with morphological changes in vivo in tumors derived from WT1-expressing cells (Figure 2 ). The tumors that developed in mice injected with wildtype NIH3T3 and ras-transformed NIH3T3 consisted of fascicles of spindly and elongated mesenchymal cells characteristic of soft tissue sarcomas. In contrast, tumors developing in mice injected with WR16, WR35 and VW9 cells displayed a mosaic-like arrangement of cells with a reduced nuclear/cytoplasmic ratio and at times formed`pseudoglandular' structures. The morphology of these tumors was interpreted blindly by a pathologist (JG in acknowledgement) to show features of carcinomatous epithelial dierentiation (Figure 2) .
The altered histopathology of the WT1-expressing NIH3T3 cells by light microscopy led us to examine Figure 1 Engineered expression of WT1 in NIH3T3 cells grown in vitro and in vivo. In vitro expression of WT1. Total RNA (20 mg) derived from the indicated WT1 transfected cell line was subjected to Northern blot analysis with the murine WT1 cDNA probe (top) and exposed to X-ray ®lm for 5 days at 7808C. Equal amounts of cellular lysate from the parental 3T3 cells or WT1 transfectants were immunoblotted with an anity puri®ed rabbit anti-WT1 antibody (Adapted from Luo et al., 1995) the histopathology in more detail by electron microscopy. Some desmosome-like structures were found in tumors that developed in mice injected with one of the WT1 expressing cell line, but never in mice injected with wild-type NIH3T3. Madin-Darby Canine Kidney (MDCK) epithelial cells were examined in parallel as a positive control (Figure 3 ) for the formation of desmosomes, which were accompanied by tighter apposition of cells and denser cytoplasmic ®laments. Signi®cantly, tumors grown in nude mice derived from WR16 that showed desmosome-like structures expressed the highest levels of WT1 in vivo (Figure 1 ).
Figure 2 (a) WT1 expression alters histopathology of NIH3T3-derived tumors in athymic mice. Tumors were derived from wildtype NIH3T3 cells, WT1-expressing NIH3T3 cell line WR16 and WR35, ras-transformed NIH3T3 cell line VAC1 and WT1-expressing, ras-transformed NIH3T3 cell line VW9. VW9a is a tumor derived from injections performed during previous work (Luo et al., 1995) and VW9b in this work. Note the mosaic-like pattern and rounded shape of cells in tumors derived from WT1 expressing tumors in contrast to the fusiform histopathology of tumors derived from the controls. Magni®cation is at 3006 (b) In vivo expression of WT1. Northern analysis of 20 mg of total mRNA extracted from tumors derived from the WT1-expressing cell lines WR16 and WR35. WT1 mRNA level is depicted at the top, while the 18S ribosomal RNA internal control is depicted at the bottom. (c) RT ± PCR analysis indicating that expression of WT1 is maintained in tumor specimens. Letter C refers to control PCR reaction without reverse transcriptase
WT1-expressing cells exhibit altered expression of markers of renal dierentiation
We tested the expression of a battery of extracellular matrix proteins (ECM), cellular adhesion molecules (CAM) and other markers important during the renal MET ( Figure 4 ). To be assured that changes in gene expression were not simply due to clonal variation, we compared three NIH3T3 cell lines expressing WT1 to the parental NIH3T3 cells, a clonal isolate of rastransfected NIH3T3 cells and two clonal isolates of cells stably transfected with the RSV promoter and neomycin resistance gene. Uvomorulin, heparan sulfate proteoglycan (HSPG), collagen IV and cytokeratin genes are up-regulated early during renal MET. Uvomorulin (E-Cadherin in human) is an epithelial marker gene important in tumor metastasis (Albelda, 1993) and can serve as a prognostic marker in renal and other malignancies (Shiozaki et al., 1996) . Compared to NIH3T3 cells, RSV vector transfected NIH3T3 cells, and VAC1, uvomorulin expression was up-regulated 8 ± 30-fold in WR14, WR16 and WR35 cells (Figure 4 ). The up-regulation of uvomorulin in WT1-expressing cell lines may re¯ect the dual function of WT1 as an inducer of epithelia and a tumor suppressor. Uvomorulin could be a target gene involved in both WT1-mediated processes. In what initially appeared to be a paradoxical manner, uvomorulin expression was down-regulated in WR16 and WR35 derived tumors (Figure 4 ), despite the continued presence of WT1 transcripts in these tumors (Figure 2b, c) . Down-regulation of uvomorulin correlates well with malignant transformation (Shiozaki et al., 1996) and the process of tumor formation in nude mice may require and select for cells with a low level of uvomorulin expression, despite the presence of WT1.
HSPG is expressed in glomerular epithelial cells, and plays an important role in determining glomerular permeability (Van den Born et al., 1992) . HSPG levels are depressed in the Denys ± Drash syndrome where WT1 is mutated (van den Heuvel et al., 1995) and hence, HSPG is a candidate direct target gene of WT1 that may be highly relevant to renal development. The level of HSPG mRNA increased up to ®vefold in WT1-expressing cells compared to NIH3T3 cells, RSV vector transfected NIH3T3 cells, and VAC1. Enhanced expression was also seen in WR16 derived tumors which showed 3.5-fold increase in HSPG mRNA compared to NIH3T3 cells derived tumors (Figure 4) .
Collagen IV is a major component of the basement membrane in epithelial cells which provides the scaold required for mechanical strength and the binding of other proteins (Yurchenco and Ruben, 1987) . Collagen IV mRNA levels were comparable in NIH3T3 cells and VAC1. Collagen IV mRNA was increased of 30-fold, sevenfold and 21-fold in WR14, WR16 and WR35 cell lines respectively compared to NIH3T3 cells, RSV vector transfected NIH3T3 cells, and VAC1. However, only the WR35 derived tumors showed a twofold increase in collagen IV expression relative to NIH3T3 cells derived tumors (Figure 4) .
While the expressions of epithelial-speci®c genes increased in cells expressing WT1, mRNA encoding vimentin, the mesenchymal intermediate ®lament cytokeratins (Klymkowsky et al., 1989) , we performed immunostaining using an antibody which recognizes a mixture of cytokeratin subtypes. Increased reactivity was detected in WT1-expressing cells grown in vitro, particularly in VW9 which expresses abundant levels of WT1 ( Figure 2 and Luo et al., 1995) . Cytokeratin expression was generally also upregulated when the cells were grown as tumors in athymic mice ( Figure 5 ). Therefore WT1 expression was associated with the coordinated up-regulation of cytokeratin and downregulation of vimentin, consistent with a mesenchymalepithelial transition.
Expression of a8 integrin
Integrins are a heterodimeric class of tissue-speci®c cell surface transmembrane glycoproteins that mediate cellcell and cell-ECM interactions (Hynes, 1992) , differentiation (Rosen et al., 1992) , proliferation (Agrez et al., 1994; Varner et al., 1995) and apoptosis (Montgomery et al., 1994) . The recently identi®ed a8 subunit which associates with the b1 subunit is the only subtype of integrin known to be expressed in a regulated manner required for the normal MET (Schnapp et al., 1995a,b; Muller et al., 1997) . During nephrogenesis, just prior to epithelialization, expression of a8 integrin subunit increases dramatically, then decreases after mesenchymal condensation and disappears at the comma and S-shape body stages where WT1 is expressed at a high level (Schnapp, unpublished; Muller et al., 1997) . Western blot analysis of WT1-expressing cell lines using an anti-integrin a8 antibody revealed striking 90 ± 100% reduction of integrin a8 protein expression compared to NIH3T3 cells ( Figure 6 ). The down-regulation of a8 integrin expression in cell culture is consistent with the notion that WT1 up-regulation during condensation of the renal mesenchyme into epithelia may be responsible for the down-regulation of a8 integrin by a direct transcriptional mechanism.
Analysis of insulin-like growth factor II
IGF-II is an autocrine regulator of cell proliferation that is involved in renal development (Hirvonen et al., 1989; Rogers et al., 1991) . IGF-II expression is elevated in both fetal kidney and in many Wilms' tumor and was proposed to function as a transforming gene in Wilms' tumor (Hastie, 1994; Hirvonen et al., 1989; Reeve et al., 1985) . Relaxation of IGF-II imprinting occurs in the Beckwith ± Wiedemann syndrome (BWS) suggesting a pathogenic role for the gene (Rainier et al., 1993; Weksberg et al., 1993) . Figure 4 shows a 3 ± 5-fold increase of IGF-II mRNA compared to NIH3T3 cells, RSV vector transfected NIH3T3 cells, and the ras-transformed line, VAC1. Furthermore, there was a marked 40-fold and 15-fold increases in IGF-II mRNA in vivo in WR16 and WR35 derived tumors respectively compared to NIH3T3 cells and VAC1 derived tumors suggesting that growth of these cells in vivo ampli®es the WT1-associated IGF-II expression (Figure 4) .
Discussion
Our data demonstrate that expression of WT1 in ®broblasts give rise to a cell type which manifests many epithelial features. WR14, WR16 and WR35
were the only three NIH3T3 cells lines stably transfected with WT1 cDNA that expressed WT1 mRNA out of approximately 30 neomycin-resistant colonies (Luo et al., 1995) . The low rate of isolation of WT1-expressing clones is likely due to the well documented growth suppressive eect of WT1 (Englert et al., 1995; Haber et al., 1993; Hewitt and Saunders, 1996; Luo et al., 1995; Menke et al., 1996; Werner et al., 1995) . The histopathologic and molecular analyses of the WR16 and WR35 tumors showed relatively consistent changes towards epithelia and tumors derived from these cells expressed appreciable amounts of WT1 mRNA comparable to those found in these cell lines in vitro (Figure 1 ). In some cases expression of epithelial markers and other potential WT1 target genes was accentuated when the WT1-expressing cells were grown in vivo in the nude mouse, despite some down-regulation of the WT1 gene (Luo et al., 1995) . This suggest that WT1 works in concert with other molecular pathways, potentially including cell adhesion molecules which aect differentiation and also suggests that continued high level expression of WT1 may not be required for the maintenance of features of an epithelial dierentiation program, once initiated. The most striking epithelioid phenotype was seen in WR16, the non-transformed NIH3T3 cell line with the highest level of WT1 expression (Figure 2 ). Further examination of these tumor tissues by electron microscopy revealed that WR16 but not WR35 cells formed desmosome-like structures (Figure 3 ) which are highly characteristic of epithelial cell types. This leads us to believe that at high levels of WT1 expression level of WR16, a threshold is reached when the mesenchymal cells become more epithelial in character. Desmosome-like structures are often observed in epithelioid sarcomas, tumors of primitive mesenchymal cells with the capacity to show epithelial dierentiation, indicating the plasticity of mesenchymal cells (Gabbiani et al., 1972; Machinami et al., 1982) .
The induction of markers of epithelial dierentiation in WT1-expressing cells con®rmed the results of the morphologic analyses and indicated that dierentiation towards an epithelial cell also occurs at the molecular level. ECMs, CAMs and other intracellular cytoskeletal proteins serve as good markers for the MET as mesenchymal and epithelial cells express dierent sets of these genes (Birchmeier and Birchmeier, 1993; Ekblom, 1989) . Many of these epithelial marker genes were up-regulated in the three WT1 expressing cell lines (Figure 4 and data not shown), while none were expressed in an NIH3T3 cell control, two independent clones of RSV vector transfected NIH3T3 cells or a ras-transformed cell line. Table 1 shows a comparison between the changes in gene expression of the epithelial markers during renal MET and in the NIH3T3 system. Thus, the pattern of gene expression of uvomorulin, HSPG, collagen IV, cytokeratin, vimentin and a8
integrin during the renal MET can be at least partially reproduced in a heterologous system like the WT1-expressing NIH3T3 ®broblast. This extends prior work which indicated that the renal marker syndecan could be induced in NIH3T3 cells by expression of WT1 (Cook et al., 1996) . The utility of the NIH3T3 system as means of identifying WT1 target genes is highlighted by the fact that the perlecan promoter contains multiple potential WT1 binding sites (Iozzo et al., 1997) and can be activated by WT1 in transient co- Our data also support the notion that WT1 may regulate the IGF-II gene. It was shown that wild-type WT1 could bind to the IGF-II promoter and repress (Drummond et al., 1992; Ward et al., 1995) transcription of the IGF-II-CAT reporter gene in transient transfections. This led to the notion that overexpression of IGF-II in Wilms' tumor (Reeve et al., 1985) could be the result of loss of transcriptional repression by a mutant WT1 (Drummond et al., 1992) . In contrast, we found that WT1-expressing ®broblasts grown in vitro up-regulated the endogenous IGF-II gene which was quite dramatic when the cells were grown as tumors in nude mice (Figure 4) . Similarly, Nichols et al. (1995) found that overexpression of either wild-type WT1 or a repression-defective mutant of WT1 in RM1 Wilms' tumor cells was associated with increased IGF-II expression. As in our system, IGF-II expression was markedly enhanced when the RM1 cells were grown in vivo in nude mice (Nichols et al., 1995) . Together these data suggest that IGF-II overexpression in the majority of sporadic Wilms' tumor could result from the high-level expression of wild-type WT1 (Little and Wells, 1997; Reddy and Licht, 1996) and not from derepression of IGF-II gene by a mutated form of WT1. Therefore in certain contexts, WT1 itself might serve as an oncogene, rather than a tumor-suppressor gene by trans-activating IGF- Figure 6 Expression of a8 integrin in WT1-expressing ®broblast. Lysates of control and WT1-expressing cells were electrophoretically separated, blotted to a membrane, and incubated with a polyclonal anti-a8 integrin antibody. The quantitation of the a8 integrin protein expression level (percentage relative to NIH3T3) as determined by scanning densitometry is indicated in the bottom Figure 7 A graphic depiction of the possible cascade of events necessary for proper induction of kidney epithelial dierentiation. In the early nephrogenesis, interaction between ureteric bud or spinal cord with mesenchyme leads to induction of mesenchymalepithelial transition (MET). This process may be accomplished by three dierent processes. (1) reciprocal interactions between ureteric bud and metanephric mesenchyme mediated by signaling factors; factors expressed in condensing metanephric mesenchyme promote further ureteric bud invasion, mesenchymal-epithelial transition and nephron maturation. Basal expression of WT1 may play a role in eliciting signal to ureteric bud and may be required for survival of metanephric mesenchyme and for ability of metanephric mesenchyme to receive signals from the ureteric bud. (2) transcription factors potentially important in the actual celltype conversion from mesenchyme to epithelium. Signaling factors such as the BMP-7, GDNF/ret, and Wnt/frizzled may contol and/or may be controlled by the expression of multiple transcription factors like WT1, Pax-2, Pax-8, Lim1, GATA-3 and others critical for renal epithelial identity. (3) Upregulation of WT1 during mesenchymal-epithelial transition may play a second role by regulating a subset of genes important in structural transformation and dierentiation of mesenchyme into epithelial cell. These and other structural genes may be most eectively induced by combined action of WT1 and other kidney speci®c transcription factors WT1 induced differentiation S Hosono et al II, and perhaps other genes important for cell proliferation. This idea supported by the ®nding that high-level expression of WT1 is associated with acute leukemia (reviewed in Pritchard-Jones and KingUnderwood, 1997). WT1 is expressed at low basal level in the metanephric mesenchyme, the precursor to the de®nitive mammalian kidney, and is upregulated during mesenchymal condensation. This expression pattern suggests a dual role of WT1 in kidney development. Gene disruption analysis showed that basal expression of WT1 is required to prevent apoptosis of the metanephric mesenchyme and for ureteric bud outgrowth into the metanephric mesenchyme (Kreidberg et al., 1993) . Hence WT1 may commit the mesenchyme towards renal dierentiation and formation of the glomerulus. Our results are consistent with a second role for WT1 as an inducer of epithelial conversion when the gene is upregulated during mesenchymal condensation. WT1, though inducing many feature of MET, did not convert the mesenchymal ®broblast to a full epithelial phenotype.
Several genes were recently identi®ed as inducers of kidney epithelial dierentiation (Figure 7) . The ret receptor/glial cell line derived neutrophic factor (GDNF) interaction (Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996; Schuchardt et al., 1994) , Emx-2 gene (Miyamoto et al., 1997) , bone morphogenetic protein 7 (BMP-7) (Lyons et al., 1995) , and Wnt-4 gene (Stark et al., 1994) have all been shown to play a role in kidney epithelial dierentiation by gene disruption in mouse and other studies. Such knockout studies indicate that receptor ligand interaction may control the expression of the second group of genes; renal speci®c transcription factors (Pax2, Pax8, WT1, Lim1, and GATA-3) which then induce the actual celltype conversion from mesenchyme to epithelium by regulation of structural genes.
The importance of cell signaling in epithelial dierentiation is underscored by the remarkable ®nding that expression of the receptor tyrosine kinase encoded by the met proto-oncogene along with its ligand, hepatocyte growth factor/scatter factor (HGF/ SF) can convert NIH3T3 cells into a transformed cell with complete epithelial features including tight junctions and desmosomes (Tsarfaty et al., 1994) . This result, along with those described in this report underscore the plasticity of the NIH3T3 ®broblast. Renal dierentiation involves the coordinated expression of multiple sequence speci®c transcription factors likely induced by extracellular clues such as those induced by the interaction between the ureteric bud and metanephric mesenchyme. In this context, it is not surprising that WT1 induces only partial epithelialization of NIH3T3 cells while engagement of an upstream signaling pathway (met-HGF/SF) can fully induce a mesenchymal-epithelial transition. It was recently shown that induction of Pax2 expression in HEK293 human fetal kidney cell line increased the expression of WT1 and E-cadherin/uvomorulin and inhibited expression of vimentin which suggested that Pax2 can partially regulate the epithelial conversion (Torban and Goodyer, 1998) . Our data is strikingly similar and indicate that WT1 might cooperate with Pax2 to regulate an overlapping subset of genes important in the structural transformation of the mesenchyme into epithelium. Complete induction of renal epithelial dierentiation may also require the combined eects of the various isoforms of WT1, WT1-transcriptional cofactors such as Par-4 (Johnstone et al., 1996) , ciao 1 (Johnstone et al., 1998) or cooperation with other transcription factors such as GATA-3 (Oosterwegel et al., 1992) .
Material and methods
Cell lines
The WT1-expressing stable cell lines and their appropriate contols that were used in this study were described previously (Luo et al., 1995) . A ras-transformed NIH3T3 cell line VAC1 and WT1-expressing ras-transformed cell line VW9 were created by calcium phosphate stable transfection of ras-transformed NIH3T3 ®broblasts with RSV expression vector alone or a vector containing the WT1 (A) isoform (-17 amino acids, -KTS) (Luo et al., 1995) . WR14, WR16, and WR35 are stable NIH3T3 cell lines expressing murine WT1(A) driven by the Rous sarcoma virus LTR.
Microscopic analysis
All cell lines were grown in DMEM supplemented with 10% fetal bovine serum (BioWhittaker, Walkersville, MD, USA) to sub-con¯uence. The cells were trypsinized, washed twice with PBS, and aliquots of 2610 7 cells were resuspended into 300 ml of PBS and injected subcutaneously into nude mice at four dierent sites, with the tumor size measured every other day. From each animal, tumors of approximately 1 cm 3 were excised and divided into three portions. One fraction was preserved in a ®xation solution of 10% picric acid and 10% acetic acid for light microscopic analysis. The other fractions were processed for electron microscopy and RNA analyses (frozen in liquid nitrogen) as described below. Thin sections of tissues were stained with toluidine blue dye, and visualized under a Nikon axiophot light microscope. Tumor tissues processed as described above were cut into approximately 1 mm 3 pieces and ®xed overnight in PBS/2% paraformaldehyde/2% glutaraldehyde at 48C. All subsequent processing was performed at 48C. The samples were then bathed three times in PBS/3.5% glucose and ®xed in 2% osmium tetroxide/3.5% glucose for 3 h. The tissues were then washed three times in PBS/3.5% glucose for 10 min each and then for three times in 0.9% saline for 30 min each. This was followed by incubation in 50, 70 and 95% ethanol for 15 min and three times with 100% ethanol for 20 min. Finally, the samples were treated with propylase oxide twice for 12 min, shaken overnight in 1 : 1 propylene oxide/EPON, and treated with pure EPON for 5 h with two changes. The samples were then embedded in EPON 812 (Polyscience, Warrington, PA, USA). Thin sections were then sliced with a diamond knife in an ultramicrotome. Transmission electron microscopy was performed using a JEM 100CX microscope (Jeol Ltd. Peabody, MA, USA).
Analysis of mRNA expression
Cytoplasmic RNAs were isolated from cell lines grown in tissue culture and resected tumor specimens as described previously (Luo et al., 1995) . Cytoplasmic RNAs from each cell line (20 mg) were used to quantify the level of expression of the dierentiation marker mRNAs by Northern analysis (Ausubel et al., 1989) . mRNA expression was quanti®ed by phosphoimager analysis using ImageQuant software (Molecular Dynamics, Sunnyvale, WT1 induced differentiation S Hosono et al CA, USA). Probes were generated by excising the cDNA insert from the vectors using appropriate restriction enzymes. The uvomorulin probe was a gift from S Mazur, Mount Sinai School of Medicine, and the HSPG/ perlecan, collagen IVa1 and IGF-II cDNAs were gifts from L Bruggemann, Mount Sinai School of Medicine. A fragment of the mouse vimentin gene was ampli®ed from murine genomic DNA by PCR using a set of primers (forward: 5'-GTC TAC CAG GTC TGT GTC CTC GTC-3' and reverse: 5'-CAT CTC CTC CTC GTA CAG GTC G-3') which amplify only exon 1. RT ± PCR analysis was performed to detect WT1 expression using primers (forward: 5'-ATG TGT GCA TAC CCA GGC at nucleotide 1447 and reverse: 5'-TGT ATG AGT CCT GGT GTG at nucleotide 1695 of the murine WT1 cDNA). RT/PCR reactions (40 cycles) were performed in the presence or absence of reverse transcriptase using the Access RT ± PCR System (Promega Corp., Madison, WI, USA).
Analysis of protein expression by immunohistochemistry
All cell lines were grown on 12 mm microscope cover glasses (Fisher) in 24-well tissue culture plates. Cells were grown to 50 ± 80% con¯uence, washed with PBS (with calcium and magnesium) for 5 min, ®xed with 100% methanol for 5 min, rinsed with PBS for 5 min, and dried overnight at room temperature. The ®xed cells were stored at 7208C until they were used. These ®xed cells were hydrated with PBS for 5 min, repermeabilized with 0.1% Triton X-100 for 3 min and treated with 0.3% H 2 O 2 / methanol for 10 min. The cells were washed three times with PBS for 3 min each. The tumor tissues were embedded into paran, sliced by mictrotome and placed onto microscope slides. The slices were dewaxed in xylene for 5 min and hydrated in a series of ethanol washes (100, 96, 80, 70, 50, 30 , and 0%) for 5 min each. The tissue section were then blocked in 0.3% H 2 O 2 /methanol for 30 min and washed with PBS twice for 10 min. Rabbit polyclonal antipan-cytokeratin (1 : 20 dilution, Amersham) and mouse monoclonal anti-uvomorulin (1 : 100 dilution, Zymed) were used in immunostaining of both tissue culture and parran-embedded tumor tissue section using the Vectastain elite ABC kit (for anti-mouse and anti-rabbit) and AEC kit (horse radish peroxidase substrate) (Vector Laboratories, Burlingame, CA, USA).
Analysis of protein expression by Western blotting
Cell lines were grown in tissue culture to 80% con¯uence and scraped into a buer consisting of 1 mM EDTA/ 150 mM NaCl/50 mM Tris-HCl and centrifuged at 5000 g. The cell pellets were solubilized in 100 ml of 200 mM octylb-D-glucopyranoside/100 mM Tris-HCl/1 mM PMSF for 1 h at 48C, centrifuged at 10 000 g at 48C for 15 min and the resulting supernatant was collected. Protein concentrations were determined using the BioRad DC kit (BioRad, Hercules, CA, USA). Protein samples (40 mg) were separated by electrophoresis under non-reducing conditions (to detect the a8 ± b1 integrin dimers) in 7.5% SDS ± PAGE and transferred to an Immobilon-P (Millipore, Bedford, MD, USA) nylon membrane. The ®lters were blocked with 1% dry milk/1% BSA/0.02% Tween-20/PBS for 2 h, incubated with anti-a8 integrin antibody (Schnapp et al., 1995a) for 1 h, rinsed in PBS, and then probed with an alkaline phosphatase conjugated goat anti-rabbit secondary antibody at a dilution of 1 : 3000 for 30 min. After rinsing in PBS, the ®lter was developed using the Protoblot alkaline phosphatase detection system (Promega). After the desired intensity was achieved, the ®lter was rinsed with water and photographed. To determine WT1 protein expression, equal quantities of total cellular protein from WT1-expressing 3T3 cells were separated through a 15% polyacrylamide gel and immunoblotted with anity puri®ed Anti-WT1 polyclonal antibody (C-19-Santa Cruz Biotechnology) utilized at a dilution of 0.1 mg ml 71 . The immunoblots were developed by chemoluminescence (ECL, Amersham) Abbreviations WT1, Wilms' tumor susceptibility gene; MET, mesenchymal-epithelial transition; ECM, extracellular matrix proteins; CAM, cellular adhesion molecules; MDCK, MadinDarby canine kidney; HSPG, heparan sulfate proteoglycan; IGF-II, Insulin-like growth factor II; HGF/SF, hepatocyte growth factor/scatter factor; RSV-Rous sarcoma virus.
